The current study shows that both CYP24A1-derived metabolites, 20,24(OH)2D3 and 1,24,25(OH)3D3, inhibit the proliferation of human melanoma A375 cells maximally by about 25%, while for SK-MEL-28 cells this effect was markedly weaker. This evidence concerns the gene CYP24A1 and melanoma.